This website allows users to text a sexual partner that they might be at risk of an STD. It will ALWAYS be anonymous. Studies have shown that anonymous notification options improve the rate of partner notification, which contributes to the successful detection, diagnosis, and treatment of transmitted infections.
This report summarizes that the third WHS was held as a predominately virtual event in 2022, with a small in-person hub at the World Health Organization in Geneva, with the theme of “Achieving the elimination of viral hepatitis within evolving health systems”. The programme introduced the new Global Health Sector Strategy (2022-2030) and explored topics across the cascade of care for hepatitis A, B, C, D and E, including barriers such as stigma and discrimination and innovations, like the potential for a functional cure for hepatitis B.
This fact sheet provides a general overview of the Minority AIDS Initiative (MAI) and the Minority HIV/AIDS Fund, emphasizing the need to reaffirm our commitment to the MAI, including increasing funding and transparency.
This webinar brings together clinicians, academics, researchers, advocates, professional societies, regulatory agencies and industry representatives to align on best practices to improve treatment for HCV in pregnancy. The TiP-HepC Community of Practice is intended for all stakeholders involved in the care of hepatitis C infection in pregnancy.
This fact sheet provides brief information on M. bovis, as well as safety and infection control measures for individuals handling carcasses of animals known or suspected to have TB.
This poster provides steps that the general public can take to prevent active TB disease.
This fact sheet discusses general information about latent TB infection (LTBI), TB transmission, and TB tests. The resource also provides information on LTBI testing, and treatment.
This guide provides clinicians with an overview of drug-resistant tuberculosis. The guide includes tools that can be used by providers who participate in the management of patients with drug-resistant TB.
This fact sheet provides general information on distinguishing between TB and COVID-19 symptoms, as well as information on some risk factors for TB.
This fact sheet aims to provide clinicians with general information on the presence of nitrosamine impurities found in rifampin and rifapentine and its impact on the treatment for TB.
